本網站使用瀏覽器紀錄 (Cookies) 來提供您最好的使用體驗，我們使用的 Cookie 也包括了第三方 Cookie。相關資訊請訪問我們的隱私權與 Cookie 政策。如果您選擇繼續瀏覽或關閉這個提示，便表示您已接受我們的網站使用條款。 關閉
TAIPEI, Sept. 15, 2023 /PRNewswire/ -- The price of PINs Network's token, PINs, has soared by 2003% since its launch on LBank Launchpad. Early investors who participated in the Launchpad have gained returns of up to $20,000, calculated based on the individual hard cap of $1,000 for this Launchpad. As a social metaverse project, PINs' official Twitter account has 14.1K followers, with individual posts getting more than 50K views and nearly 6K interactions. Though there's still a gap compared to top-tier projects, its recent growth in the bear market suggests other forces at play. So why did the price of PINS' token see such a significant increase? Two factors—South Korea's cryptocurrency market and LBank's support— can explain PINS' surge. 1. South Korea's Crypto Market The timeline of PINS' price rebound coincides with Korea's "KBW2023" summit, which was heavily promoted in Korea. In fact, PINs has always been closely watching the Korean market. A Twitter user named Hamid has been a staunch supporter since day one, stating that PINS is about to release its whitepaper in Korean and has established a local marketing team. PINS is also planning various activities for Korean users, both online and offline. This momentum reminds people of Ripple (XRP) in 2017, where 50% of the trading volume was propelled by Korean individual investors, resulting in a 10x increase in a few weeks. Recently, $Cyber also saw a sharp rise, said to be led by the Korean market, creating a notable "kimchi premium" where the price on Korean exchanges like Upbit is significantly higher than other exchanges. Furthermore, according to an LBank official, nearly half of PINS's close to $100 million trading volume on September 14 came from Korean IP addresses. 2. LBank's Support As the exchange leading this PINS Launchpad, LBank is an essential force in boosting PINs' price. LBank has performed strongly among many exchanges this year, giving them the confidence to push this Launchpad even in a bear market. According to a CMC report, LBank captured 4.6% market share in the first half of this year, ranking 5th in spot trading volume. Their strategic focus on MEME coins, often considered high-risk due to their volatility, was a catalyst for this growth. LBank has been effective in listing quality MEME coins, thereby building a reputation for reliability. Additionally, LBank is also focused on the Korean market. Last month, Bithumb officially announced a whitelist partnership with LBank, allowing unrestricted transfers between the two for all Korean users. LBank has now joined the local Code VASP compliance alliance after passing local regulatory requirements. LBank's official Twitter account has over 448K followers, with each post getting between 5K and 1M views. LBank's extensive promotion in their community highlights the importance of this Launchpad in their recent strategy. Conclusion In summary, the significant price increase of PINS' token is the result of a combination of the Korean crypto market and LBank's strategic support, enabling PINS to maintain strong price performance even in a bear market. This indicates the enormous growth potential for PINs in the social metaverse sector, as well as LBank's powerful influence in pushing emerging projects this year. Furthermore, LBank has already launched the second project of its Launchpad, MetaExpand (UMM).
TAIPEI, Sept. 15, 2023 /PRNewswire/ -- As the eagerly awaited MWC 2023 approaches, AsiaRF Corp., a leader in wireless communications since its inception in 1996, offers a sneak peek into its groundbreaking global launch. The Taiwanese tech giant is gearing up to introduce a revolutionary Wi-Fi HaLow IoT solution that promises to disrupt industrial internet of things connectivity. 3D rendering exhibition illustration background Advancing Wi-Fi HaLow Technology Wi-Fi HaLow technology impresses with its astounding operational range of up to one kilometer and ultra-low power requirements. AsiaRF's Wi-Fi HaLow Gateway AP7688-WHM, powered by Morse Micro's MM610X chip (the fastest HaLow solution on the planet), has not only achieved worldwide recognition but also secured the world's first Wi-Fi HaLow CERTIFIED end-product from the Wi-Fi Alliance. This milestone accentuates AsiaRF's leadership and innovative capabilities in IoT connectivity. Thanks to the persistent efforts of its R&D team, AsiaRF plans to unveil a series of Wi-Fi HaLow solutions at the upcoming MWC 2023. These include wearable mobile network devices, indoor APs, outdoor gateways, relays, and a DIY solution kit with various functional interfaces that cover a plethora of applications from smart agriculture to industrial automation, healthcare, and intelligent transport. Meet Us at MWC Las Vegas 2023 For an in-depth look into AsiaRF's revolutionary technologies, join us at The HUB Startup Booth 1712, 1714 during MWC 2023 in Las Vegas. Our team will be available to discuss our solutions, offer live demonstrations, and explore partnership opportunities. Beyond Expectations: Multi-Dimensional Connectivity AsiaRF's focus isn't limited to Wi-Fi HaLow; their premium Wi-Fi 6E module, AP7916-NPD, powered by industry leader MTK (MediaTek), promises a seamless internet experience with tri-band advantages. These modules are geared towards the next generation of wireless electronic products and enterprise networks, offering faster speeds and lower latency. Looking Ahead AsiaRF has already established partnerships with global leaders in the IoT space and is actively seeking strategic collaborations across various sectors. For the latest updates on AsiaRF's innovative solutions, please visit the AsiaRF Official Website. or contact directly at sales@asiarf.com. About AsiaRF AsiaRF has been a leading provider of wireless connectivity solutions since its inception in 1996. Our mission is to make IoT technology more accessible, efficient, and practical to expand the horizons of people's lives and work. For more information, visit AsiaRF Official Website. About Morse Micro Founded in 2016, Morse Micro has the largest independent Wi-Fi design team in the world committed to driving the next generation of connectivity for the Internet of Things (IoT) through their award winning Wi-Fi HaLow device solutions. For more information, visit Morse Micro Official Website. About MediaTek MediaTek is a global fabless semiconductor company that enables more than 2 billion consumer products a year. MTK is a market leader in developing tightly-integrated, power-efficient systems-on-chip (SoC) for mobile devices, home entertainment, network and connectivity, automated driving, and IoT. For more information, visit MediaTek Official Website. CONTACT: Rebecca Hung, +886 2 8943 1001, media@asiarf.com
HONG KONG, Sept. 15, 2023 /PRNewswire/ -- Prenetics Global Limited (NASDAQ: PRE) ("Prenetics" or the "Company"), a leading genomics-driven health sciences company, today announced financial results for the second quarter ended June 30, 2023, along with recent business updates. Second Quarter 2023 Financial Highlights Revenue from continuing operations of US$5.7 million Adjusted EBITDA from continuing operations of US$(5.3) million Cash and other short-term assets[1] of US$214.5 million as of June 30, 2023 First Half 2023 Financial Highlights Revenue from continuing operations of US$11.6 million Adjusted EBITDA from continuing operations of US$(15.1) million "We've always maintained that 2023 would be a transformative year for Prenetics, and our recent strides underscore that belief. We've channelled significant investments into areas where we see not just potential, but a clear path to dominance. Our collaboration with Prof. Dennis Lo, particularly in the realm of early cancer detection, stands as a testament to our commitment and vision. Today, our future business strategy is crystallized into three distinct yet interconnected units: prevention, early cancer detection, and targeted therapy. I am both extremely excited and optimistic about the trajectory we're on, and I believe that the best is yet to come for Prenetics." said Danny Yeung, Chief Executive Officer and Co-Founder of Prenetics. Recent Highlights Completed transaction with Prof. Dennis Lo for Insighta as a 50/50 Joint Venture for Multi-Cancer Early Detection in July 2023. Prenetics provided US$100m in consideration, with US$80m in cash and US$20m of shares in Prenetics. Initial clinical trial data is promising. A large multi-country overseas clinical trial is set to begin in early 2024. ACT Genomics is expected to launch a 500-gene panel and a 100-gene panel comprehensive genomic profiling "liquid" biopsy test by the fourth quarter of 2023. ACT Genomics product development work continues for a Minimal Residual Disease (MRD) test is expected to be rolled out by Q2 2024. Multiple distribution and partnership deals are being discussed for Southeast Asia and in the Middle East. More details will be shared once available. Significant improvement in operational efficiency and cost optimization, reducing adjusted EBITDA from continuing operations from a loss of US$(9.8) million in the first quarter of 2023 to US$(5.3) million in the current quarter with further reductions expected in the second half of 2023. About Prenetics Prenetics (NASDAQ:PRE), a leading genomics-driven health sciences company, is revolutionizing prevention, early detection, and treatment. Our prevention arm, CircleDNA, uses whole exome sequencing to offer the world's most comprehensive consumer DNA test. Insighta, our US$200 million joint venture with renowned scientist Prof. Dennis Lo, underscores our unwavering commitment to saving lives through pioneering multi-cancer early detection technologies. Insighta plans to introduce Presight for lung and liver cancers in 2025, and to expand with Presight One for 10+ cancers in 2027. Lastly, ACT Genomics, our treatment unit, is the first Asia-based company to achieve FDA clearance for comprehensive genomic profiling of solid tumors via ACTOnco. Each of Prenetics' units synergistically enhances our global impact on health, truly embodying our commitment to 'enhancing life through science'. To learn more about Prenetics, please visit www.prenetics.com Forward-Looking Statements This press release contains forward-looking statements. These statements are made under the "safe harbor" provisions of the U.S. Private Securities Litigation Reform Act of 1995. Statements that are not historical facts, including statements about the Company's goals, targets, projections, outlooks, beliefs, expectations, strategy, plans, objectives of management for future operations of the Company, and growth opportunities are forward-looking statements. In some cases, forward-looking statements can be identified by words or phrases such as "may," "will," "expect," "anticipate," "target," "aim," "estimate," "intend," "plan," "believe," "potential," "continue," "is/are likely to" or other similar expressions. Forward-looking statements are based upon estimates and forecasts and reflect the views, assumptions, expectations, and opinions of the Company, which involve inherent risks and uncertainties, therefore they should not be relied upon as being necessarily indicative of future results. A number of factors could cause actual results to differ materially from those contained in any forward-looking statement, including but not limited to: the Company's ability to further develop and grow its business, including new products and services; its ability to execute on its new business strategy in genomics, precision oncology, and specifically, early detection for cancer; the results of case control studies and/or clinical trials; and its ability to identify and execute on M&A opportunities, especially in precision oncology. In addition to the foregoing factors, you should also carefully consider the other risks and uncertainties described in the "Risk Factors" section of the Company's most recent registration statement on Form F-1 and the prospectus therein, and the other documents filed by the Company from time to time with the U.S. Securities and Exchange Commission. All information provided in this press release is as of the date of this press release, and the Company does not undertake any duty to update such information, except as required under applicable law. Basis of Presentation Unaudited Financial Information and Non-IFRS Financial Measures has been provided in the financial statements tables included at the end of this press release. An explanation of these measures is also included below under the heading "Unaudited Financial Information and Non-IFRS Financial Measures." Unaudited Financial Information and Non-IFRS Financial Measures To supplement Prenetics' consolidated financial statements prepared in accordance with International Financial Reporting Standards ("IFRS"), the Company is providing non-IFRS measures, adjusted EBITDA from continuing operations, adjusted gross profit from continuing operations and adjusted (loss)/profit attributable to equity shareholders of Prenetics. These non-IFRS financial measures are not based on any standardized methodology prescribed by IFRS and are not necessarily comparable to similarly-titled measures presented by other companies. Management believes these non-IFRS financial measures are useful to investors in evaluating the Company's ongoing operating results and trends. Management is excluding from some or all of its non-IFRS results (1) Employee equity-settled share-based payment expenses, (2) depreciation and amortization, (3) finance income and exchange gain or loss, net, and (4) certain items that may not be indicative of our business, results of operations, or outlook, including but not limited to non-cash and/ or non-recurring items. These non-IFRS financial measures are limited in value because they exclude certain items that may have a material impact on the reported financial results. Management accounts for this limitation by analyzing results on an IFRS basis as well as a non-IFRS basis and also by providing IFRS measures in the Company's public disclosures. In addition, other companies, including companies in the same industry, may not use the same non-IFRS measures or may calculate these metrics in a different manner than management or may use other financial measures to evaluate their performance, all of which could reduce the usefulness of these non-IFRS measures as comparative measures. Because of these limitations, the Company's non-IFRS financial measures should not be considered in isolation from, or as a substitute for, financial information prepared in accordance with IFRS. Investors are encouraged to review the non-IFRS reconciliations provided in the tables captioned "Reconciliation of loss from operations from continuing operations under IFRS and adjusted EBITDA from continuing operations (Non-IFRS)", "Reconciliation of gross profit from continuing operations under IFRS and adjusted gross profit from continuing operations (Non-IFRS)" and "Reconciliation of (loss)/profit attributable to equity shareholders of Prenetics under IFRS and adjusted (loss)/profit attributable to equity shareholders of Prenetics (Non-IFRS)" set forth at the end of this document. PRENETICS GLOBAL LIMITED Unaudited consolidated statements of financial position (Expressed in United States dollars unless otherwise indicated) June 30, March 31, December 31, 2023 2023 2022 $ $ $ Assets Property, plant and equipment 10,031,570 11,809,757 13,102,546 Intangible assets 14,101,566 14,463,400 14,785,875 Goodwill 33,800,276 33,800,276 33,800,276 Interests in associates 559,193 677,339 788,472 Deferred tax assets 7,631 7,626 243,449 Deferred expenses 7,097,641 5,119,170 6,307,834 Other non-current assets 741,816 1,064,194 1,292,462 Non-current assets 66,339,693 66,941,762 70,320,914 Deferred expenses 8,588,431 4,547,611 4,577,255 Inventories 3,768,880 3,420,013 4,534,072 Trade receivables 5,636,969 5,718,516 41,691,913 Deposits, prepayments and other receivables 5,594,273 6,488,436 6,889,114 Amount due from an associate 138,781 181,942 - Financial assets at fair value through profit or loss 13,593,201 17,537,608 17,537,608 Short-term deposits - 19,872,581 19,920,160 Cash and cash equivalents 177,179,297 166,335,875 146,660,195 Current assets 214,499,832 224,102,582 241,810,317 Total assets 280,839,525 291,044,344 312,131,231 Liabilities Deferred tax liabilities 2,694,720 2,924,369 3,185,440 Warrant liabilities 1,822,139 2,314,609 3,574,885 Lease liabilities 3,255,461 3,627,663 3,763,230 Other non-current liabilities 823,082 830,562 949,701 Non-current liabilities 8,595,402 9,697,203 11,473,256 Trade payables 4,226,392 7,505,724 7,291,133 Accrued expenses and other current liabilities 19,349,105 6,460,445 15,611,421 Contract liabilities 3,703,874 4,917,268 5,674,290 Lease liabilities 2,779,193 2,779,426 2,882,933 Liabilities for puttable financial instrument[2] 13,435,228 17,459,600 17,138,905 Tax payable 8,534,527 8,692,193 8,596,433 Current liabilities 52,028,319 47,814,656 57,195,115 Total liabilities 60,623,721 57,511,859 68,668,371 Equity Share capital[3] 15,791 15,882 13,698 Reserves 215,291,050 228,232,194 237,050,429 Total equity attributable to equity shareholders of the Company 215,306,841 228,248,076 237,064,127 Non-controlling interests 4,908,963 5,284,409 6,398,733 Total equity 220,215,804 233,532,485 243,462,860 Total equity and liabilities 280,839,525 291,044,344 312,131,231 PRENETICS GLOBAL LIMITED Unaudited consolidated statements of profit or loss and other comprehensive income (Expressed in United States dollars unless otherwise indicated) For the six months ended June 30, June 30, 2023 2022 $ $ (Restated) Continuing operations Revenue 11,600,319 8,291,318 Direct costs (6,988,941) (5,524,587) Gross profit 4,611,378 2,766,731 Other income and other net gain/(losses) 2,629,405 (585,463) Selling and distribution expenses[4] (4,672,953) (2,454,979) Research and development expenses[4] (6,177,592) (3,941,463) Administrative and other operating expenses[4] (23,158,344) (36,608,463) Loss from operations (26,768,106) (40,823,637) Fair value loss on financial assets at fair value through profit or loss (3,944,407) (1,659,343) Share-based payments on listing[5] - (89,546,601) Fair value loss on preference shares liabilities - (60,091,353) Fair value gain/(loss) on warrant liabilities 1,752,746 (1,539,577) Share of losses of associates (225,284) - Other finance costs (108,358) (3,883,002) Loss before taxation (29,293,409) (197,543,513) Income tax credit 268,827 1,971,231 Loss from continuing operations (29,024,582) (195,572,282) Discontinued operation (Loss)/profit from discontinued operation, net of tax[6] (4,156,608) 18,409,191 Loss for the period (33,181,190) (177,163,091) Other comprehensive income for the period Item that may be reclassified subsequently to profit or loss: Exchange difference on translation of: - financial statements of subsidiaries outside Hong Kong 1,157,683 (4,775,936) Total comprehensive income for the period (32,023,507) (181,939,027) Loss attributable to: Equity shareholders of Prenetics (32,206,003) (177,163,044) Non-controlling interests (975,187) (47) (33,181,190) (177,163,091) Total comprehensive income attributable to: Equity shareholders of Prenetics (30,533,737) (181,938,980) Non-controlling interests (1,489,770) (47) (32,023,507) (181,939,027) Loss per share: Basic (0.20) (3.57) Diluted (0.20) (3.57) Loss per share - Continuing operations: Basic (0.18) (3.94) Diluted (0.18) (3.94) Weighted average number of common shares: Basic 158,656,029 49,616,648 Diluted 158,656,029 49,616,648 PRENETICS GLOBAL LIMITED Unaudited consolidated statements of profit or loss and other comprehensive income (Expressed in United States dollars unless otherwise indicated) For the three months ended June 30, March 31, June 30, 2023 2023 2022 $ $ $ (Restated) (Restated) Continuing operations Revenue 5,695,579 5,904,740 4,183,499 Direct costs (3,559,119) (3,429,822) (2,822,908) Gross profit 2,136,460 2,474,918 1,360,591 Other income and other net gain/(losses) 1,406,281 1,223,124 (556,361) Selling and distribution expenses[4] (2,171,640) (2,501,313) (1,132,136) Research and development expenses[4] (2,703,038) (3,474,554) (2,192,768) Administrative and other operating expenses[4] (10,834,043) (12,324,301) (20,267,592) Loss from operations (12,165,980) (14,602,126) (22,788,266) Fair value loss on financial assets at fair value through profit or loss (3,944,407) - (1,659,343) Share-based payments on listing[5] - - (89,546,601) Fair value loss on preference shares liabilities - - (31,815,352) Fair value gain/(loss) on warrant liabilities 492,470 1,260,276 (1,539,577) Share of losses of associates (112,533) (112,751) - Other finance costs (51,464) (56,894) (1,420,446) Loss before taxation (15,781,914) (13,511,495) (148,769,585) Income tax credit/(expense) 245,877 22,950 (246,859) Loss from continuing operations (15,536,037) (13,488,545) (149,016,444) Discontinued operation (Loss)/profit from discontinued operation, net of tax[6] (6,671,413) 2,514,805 4,839,249 Loss for the period (22,207,450) (10,973,740) (144,177,195) Other comprehensive income for the period Item that may be reclassified subsequently to profit or loss: Exchange difference on translation of: - financial statements of subsidiaries and associates outside Hong Kong 1,794,185 (636,502) (4,245,198) Total comprehensive income for the period (20,413,265) (11,610,242) (148,422,393) Loss attributable to: Equity shareholders of Prenetics (21,807,573) (10,398,430) (144,177,194) Non-controlling interests (399,877) (575,310) (1) (22,207,450) (10,973,740) (144,177,195) Total comprehensive income attributable to: Equity shareholders of Prenetics (20,037,819) (10,495,918) (148,422,392) Non-controlling interests (375,446) (1,114,324) (1) (20,413,265) (11,610,242) (148,422,393) Loss per share: Basic (0.14) (0.07) (2.91) Diluted (0.14) (0.07) (2.91) Loss per share - Continuing operations: Basic (0.10) (0.08) (3.00) Diluted (0.10) (0.08) (3.00) Weighted average number of common shares: Basic 158,963,468 157,839,309 49,616,648 Diluted 158,963,468 157,839,309 49,616,648 PRENETICS GLOBAL LIMITED Unaudited Financial Information and Non-IFRS Financial Measures (Expressed in United States dollars unless otherwise indicated) Reconciliation of loss from operations from continuing operations under IFRS and adjusted EBITDA from continuing operations (Non-IFRS) For the six months ended June 30, June 30, 2023 2022 $ $ (Restated) Loss from operations from continuing operations under IFRS (26,768,106) (40,823,637) Employee equity-settled share-based payment expenses 6,237,845 17,960,605 Depreciation and amortization 3,935,194 924,050 Other strategic financing, transactional expense and non-recurring expenses 4,002,301 9,202,912 Finance income, exchange gain or loss, net (2,469,946) 703,368 Adjusted EBITDA from continuing operations (Non-IFRS) (15,062,712) (12,032,702) Reconciliation of gross profit from continuing operations under IFRS and adjusted gross profit from continuing operations (Non-IFRS) For the six months ended June 30, June 30, 2023 2022 $ $ (Restated) Gross profit from continuing operations under IFRS 4,611,378 2,766,731 Depreciation and amortization 719,974 51,786 Adjusted gross profit from continuing operations (Non-IFRS) 5,331,352 2,818,517 Reconciliation of loss attributable to equity shareholders of Prenetics under IFRS and adjusted (loss)/profit attributable to equity shareholders of Prenetics (Non-IFRS) For the six months ended June 30, June 30, 2023 2022 $ $ (Restated) Loss attributable to equity shareholders of Prenetics under IFRS (32,206,003) (177,163,044) Employee equity-settled share-based payment expenses 6,237,845 22,344,081 Other strategic financing, transactional expense and non-recurring expenses 9,917,705 10,549,874 Share-based payment on listing - 89,546,601 Fair value loss on preference shares liabilities - 60,091,353 Fair value (gain)/loss on warrant liabilities (1,752,746) 1,539,577 Fair value loss on financial assets at fair value through profit or loss 3,944,407 1,659,343 Adjusted (loss)/profit attributable to equity shareholders of Prenetics (Non-IFRS) (13,858,792) 8,567,785 PRENETICS GLOBAL LIMITED Unaudited Financial Information and Non-IFRS Financial Measures (Expressed in United States dollars unless otherwise indicated) Reconciliation of loss from operations from continuing operations under IFRS and adjusted EBITDA from continuing operations (Non-IFRS) For the three months ended June 30, March 31, June 30, 2023 2023 2022 $ $ $ (Restated) (Restated) Loss from operations from continuing operations under IFRS (12,165,980) (14,602,126) (22,788,266) Employee equity-settled share-based payment expenses 3,296,861 2,940,984 10,215,945 Depreciation and amortization 1,863,626 2,071,568 230,422 Other strategic financing, transactional expense and non-recurring expenses 3,077,902 924,399 7,638,653 Finance income, exchange gain or loss, net (1,323,782) (1,146,164) 671,596 Adjusted EBITDA from continuing operations (Non-IFRS) (5,251,373) (9,811,339) (4,031,650) Reconciliation of gross profit from continuing operations under IFRS and adjusted gross profit from continuing operations (Non-IFRS) For the three months ended June 30, March 31, June 30, 2023 2023 2022 $ $ $ (Restated) (Restated) Gross profit from continuing operations under IFRS 2,136,460 2,474,918 1,360,591 Depreciation and amortization 335,648 384,326 26,729 Adjusted gross profit from continuing operations (Non-IFRS) 2,472,108 2,859,244 1,387,320 Reconciliation of loss attributable to equity shareholders of Prenetics under IFRS and adjusted (loss)/profit attributable to equity shareholders of Prenetics (Non-IFRS) For the three months ended June 30, March 31, June 30, 2023 2023 2022 $ $ $ (Restated) (Restated) Loss attributable to equity shareholders of Prenetics under IFRS (21,807,573) (10,398,430) (144,177,194) Employee equity-settled share-based payment expenses 3,113,656 3,124,189 12,966,966 Other strategic financing, transactional expense and non-recurring expenses 7,678,799 2,238,906 8,854,689 Share-based payment on listing - - 89,546,601 Fair value loss on preference shares liabilities - - 31,815,352 Fair value (gain)/loss on warrant liabilities (492,470) (1,260,276) 1,539,577 Fair value loss on financial assets at fair value through profit or loss 3,944,407 - 1,659,343 Adjusted (loss)/profit attributable to equity shareholders of Prenetics (Non-IFRS) (7,563,181) (6,295,611) 2,205,334 [1] Represents current assets, including cash and cash equivalents totaling US$177.2 million, financial assets at fair value through profit or loss of US$13.6 million, and trade receivables of US$5.6 million, amongst other accounting line items under current assets. [2] In connection with the acquisition of ACT Genomics, the remaining shareholders of ACT Genomics - representing 25.61% of the fully diluted shareholding of ACT Genomics that Prenetics does not own - were granted put options which allow these remaining shareholders to put their remaining shares to Prenetics under certain conditions. The liabilities arising from such put option are recorded as liabilities for puttable financial instrument, and are valued at the present value of the exercise price of the put option. [3] Represents number of authorized and issued shares as follows: June 30, March 31, December 31, 2023 2023 2022 Number of authorized shares of $0.0001 each 500,000,000 500,000,000 500,000,000 Number of issued shares 157,905,434 158,820,280 136,983,110 [4] Includes equity-settled share-based payment expenses (excluding share-based payment on listing) from continuing operations as follows: For the six months ended June 30, June 30, 2023 2022 $ $ (Restated) Selling and distribution expenses 103,868 31,424 Research and development expenses 1,360,896 1,245,847 Administrative and other operating expenses 4,731,546 16,489,378 Total equity-settled share-based payment expenses (excluding share-based payment on listing) 6,196,310 17,766,649 For the three months ended June 30, March 31, June 30, 2023 2023 2022 $ $ $ (Restated) (Restated) Selling and distribution expenses 58,613 45,255 23,745 Research and development expenses 874,389 486,507 708,511 Administrative and other operating expenses 2,340,502 2,391,044 9,511,007 Total equity-settled share-based payment expenses (excluding share-based payment on listing) 3,273,504 2,922,806 10,243,263 [5] The acquisition of the net assets of Artisan Acquisition Corp. ("Artisan") on May 18, 2022 does not meet the definition of a business under IFRS and has therefore been accounted for as a share-based payment. The excess of fair value of Prenetics shares issued over the fair value of Artisan's identifiable net assets acquired represents compensation for the service of a stock exchange listing for its shares and is expensed as incurred. [6] We ceased our COVID-19 testing business entirely in 2023 Q2. As a result, COVID-19 testing business is reported as a discontinued operation under IFRS 5 Non-current Assets Held for Sale and Discontinued Operations. In accordance with IFRS 5, the results of the discontinued operation have been presented separately from the continuing operations in the consolidated statements of profit or loss and other comprehensive income. The comparative information in the consolidated statements of profit or loss and other comprehensive income has also been re-presented to show the results of discontinued operation separately.
CHANGZHOU, China, Sept. 15, 2023 /PRNewswire/ -- On September 12, the "Jiangsu-Germany Dialogue 2023" was held in Changzhou. This marks the third year of the event being hosted in Changzhou. The conference, themed "New Energy, New Opportunities", aims to further promote cooperation between China and Germany in fields such as trade, the new energy industry, and the digital economy. At the conference, 11 key Sino-German cooperation projects covering areas like new energy, new materials, smart manufacturing, biomedicine, and education were signed. In recent years, companies like Siemens, Thyssenkrupp, Bosch, Volkswagen, and Lanxuss have made substantial investments in Changzhou, forming German investment clusters in the city. These include the Sino-German (Changzhou) Innovation Park, the Wujin High-Tech Zone, and the Xue's Foreign Capital Town. As of the end of last year, Changzhou had a total of 247 German-funded enterprises, mainly engaged in sectors such as automotive electronics, machinery and equipment manufacturing, new materials, new energy, and environmental protection. At the same time, Germany is also an important destination for outbound investments from Changzhou, with 52 projects settling in Germany, ranking first in Changzhou's investment in Europe. Shi Mingde, President of China-Germany Friendship Association, stated that Changzhou, as a well-known manufacturing city in China, has always aimed to internationalize and benchmark itself against Germany. It has already established a favorable momentum in Sino-German cooperation. The organization of the "Jiangsu-Germany Dialogue 2023" will build a bridge for deepening cooperation in the new energy industry between China and Germany. Lukas Meyer, Deputy Consul General of the Federal Republic of Germany in Shanghai, mentioned that "Jiangsu-Germany Dialogue" activities have witnessed the strong and enduring partnership between the two countries. The Sino-German (Changzhou) Innovation Park has become the preferred destination for small and medium-sized German-speaking enterprises seeking development in China. Changzhou is committed to deepening and expanding cooperation with Germany in fields such as technology, vocational training, and culture, which has strengthened economic relations and promoted the exchange of knowledge, perspectives, and values between the two sides. During the conference, the "German & Austrian Entrepreneur Alliance" was officially launched. It is a bi-directional exchange platform established in the context of the dual carbon economy, focusing on sharing the latest industry information and entrepreneurial experiences in complementary industries between China and Europe.
BANGKOK, Sept. 15, 2023 /PRNewswire/ -- TotalEnergies ENEOS and PTT Global Chemical (GC) celebrated the official launching of a total capacity of 6.7 megawatt-peak (MWp) solar photovoltaic (PV) system for GC's 5 production facilities in Thailand. GC is Thailand's largest integrated petrochemical and refining business and a leading corporation in the Asia-Pacific region, with a target to reduce greenhouse gas emissions for 20 percent by 2030 on its journey towards achieving Net Zero emissions by 2050. Celebration of the official launching of GC’s rooftop-mounted solar systems installed by TotalEnergies ENEOS As a global chemical company committed to creating a better quality of life for all, the installation of the solar rooftops further demonstrates GC Group's commitment to reduce their carbon footprint and fulfill their sustainability targets while saving power costs, without any business disruption. GC is collaborating with TotalEnergies ENEOS, known for their robust technical experience in deploying renewable energy solutions on highly technical and complex sites, to support them in their transition towards clean energy. With over 11,000 of solar panels installed onto the rooftops of the company's 5 facilities, the 6.7 MWp PV systems generates approximately 9,500 megawatt-hours (MWh) of renewable energy annually, realising significant cost savings for GC and reducing the company's carbon footprint by about 4,300 tonnes of CO2 emissions annually, equivalent to planting more than 64,500 trees over the contract period. Under the agreement, TotalEnergies ENEOS operates the installed PV solar system while GC promptly buys the electricity generated for 20 years, without taking any upfront investments. TotalEnergies ENEOS guarantees the best performance of the system so GC can enjoy the economic and environmental benefits of the solar rooftop system, without any operational concerns. Panchoak Auetanapa, Acting Senior Vice President of Utilities Business Unit PTT Global Chemical Public Company Limited (GC), "GC is aware of global warming problems, we committed to develop and utilize the clean energy to reduce the greenhouse gas emissions to slow down the climate crisis. We intend to implement the renewable energy projects to cover all potential space of GC Group. This will transform our petrochemical plants to be a low carbon process and produce the low carbon products which pass on this value to customers who use GC's products. And the end consumers would be a part to make the environmental sustainability together. The cooperation between GC and TotalEnergies ENEOS would be a good starting point for both companies that have shown our strong commitment to be a part of many other leading companies in the world, to reduce the impact of climate change and ready to support the reduction of greenhouse gas emissions to achieve the goal of Net Zero together." Elodie Renaud, Director of TotalEnergies ENEOS Renewables Distributed Generation Asia, congratulates both GC and TotalEnergies ENEOS teams on the successful launch of the system and said, "We are honoured to be trusted by PTT Global Chemical to be a long-term energy partner on this 6.7 MWp project and support the company on their decarbonization journey. As the leading provider of solar solutions in the region, TotalEnergies ENEOS commits on the quality and reliability of our operations over the 20 years to provide peace of mind from a technical, financial, and commercial perspective. We are proud to celebrate this project as a key milestone of a long-term partnership with PTT Global Chemical." To learn more about TotalEnergies ENEOS tailored solar solutions, check out the free brochure, or contact directly for more information. About TotalEnergies ENEOS Renewables Distributed Generation Asia Pte. Ltd. The company is a 50/50 joint venture between TotalEnergies and ENEOS to develop onsite B2B solar distributed generation across Asia. It is headquartered in Singapore with a plan to develop 2 GW of decentralized solar capacity over the next five years.https://solar.totalenergies.asia TotalEnergies and renewables electricity As part of its ambition to get to net zero by 2050, TotalEnergies is building a portfolio of activities in electricity and renewables. At the end of Q2 2023, TotalEnergies' gross renewable electricity generation installed capacity was 19 GW. TotalEnergies will continue to expand this business to reach 35 GW of gross production capacity from renewable sources and storage by 2025, and then 100 GW by 2030 with the objective of being among the world's top 5 producers of electricity from wind and solar energy. https://renewables.totalenergies.com/en ENEOS Corporation and renewables electricity ENEOS operates over 20 solar power plants in Japan and are also participating in renewable energy projects in the United States, Australia, and Vietnam. Furthermore, ENEOS is actively engaged in power generation projects using biomass, hydroelectric power, wind power, etc. This joint venture is ENEOS' first overseas renewable energy project using distributed power sources. About TotalEnergies TotalEnergies is a global multi-energy company that produces and markets energies: oil and biofuels, natural gas and green gases, renewables and electricity. Our more than 100,000 employees are committed to energy that is ever more affordable, cleaner, more reliable and accessible to as many people as possible. Active in more than 130 countries, TotalEnergies puts sustainable development in all its dimensions at the heart of its projects and operations to contribute to the well-being of people. Twitter @TotalEnergies LinkedIn TotalEnergies Facebook TotalEnergies Instagram TotalEnergies About ENEOS Corporation ENEOS Group has developed businesses in the energy and nonferrous metals segments, from upstream to downstream. The Group's envisioned goals for 2040 are: becoming one of the most prominent and internationally competitive energy and materials company groups in Asia, creating value by transforming our current business structure, and contributing to the development of a low-carbon, recycling-oriented society with the pursuit of carbon-neutral status in its own CO2 emissions. ENEOS Corporation, one of the principal operating companies in the Group, is contributing to achievement of the Group's envisioned goals through a broad range of energy businesses. About PTT Global Chemical Public Company Limited PTT Global Chemical Public Company Limited, or GC is Thailand's largest integrated petrochemical and refining business and a leading corporation in Asia-Pacific region, both in size and wide range of products – from petrochemical to biochemical with the world's number 1 bioplastics producer. We are the world number one in chemical sector in Dow Jones Sustainability indices for three consecutive years. Also, we have been rated at Leadership Level (A List) in water management and environmental management in climate change by CDP. Aligned with the Paris Agreement, we aim to reduce current CO2 emissions for 20 percent by 2030 on our journey towards achieving Net Zero by 2050.www.pttgcgroup.com TotalEnergies ENEOS ContactsMedia Relations: contact.solar.asia@totalenergies.com PTT Global Chemical Public Company Limited ContactsChintarat Saiintawong: chintarat.s@pttgcgroup.com Siriporn Sukhapunnapan: siriporn.su@pttgcgroup.com Cautionary Note TotalEnergies The terms "TotalEnergies", "TotalEnergies company" or "Company" in this document are used to designate TotalEnergies SE and the consolidated entities that are directly or indirectly controlled by TotalEnergies SE. Likewise, the words "we", "us" and "our" may also be used to refer to these entities or to their employees. The entities in which TotalEnergies SE directly or indirectly owns a shareholding are separate legal entities. This document may contain forward-looking information and statements that are based on a number of economic data and assumptions made in a given economic, competitive and regulatory environment. They may prove to be inaccurate in the future and are subject to a number of risk factors. Neither TotalEnergies SE nor any of its subsidiaries assumes any obligation to update publicly any forward-looking information or statement, objectives or trends contained in this document whether as a result of new information, future events or otherwise. Information concerning risk factors, that may affect TotalEnergies' financial results or activities is provided in the most recent Registration Document, the French-language version of which is filed by TotalEnergies SE with the French securities regulator Autorité des Marchés Financiers (AMF), and in the Form 20-F filed with the United States Securities and Exchange Commission (SEC). Cautionary Note ENEOS Corporation The terms "ENEOS", "ENEOS Group" in this document are used to designate ENEOS Corporation and the consolidated entities that are directly or indirectly controlled by ENEOS Corporation. This document contains certain forward-looking statements. Actual results may differ materially from those reflected in any forward-looking statement due to various factors, which include, but are not limited to, the following: (1) macroeconomic conditions and changes in the competitive environment in the energy, resources, and materials industries; (2) the impact of COVID-19 on economic activity; (3) changes in laws and regulations; and (4) risks related to litigation and other legal proceedings.
LAS VEGAS, Sept. 15, 2023 /PRNewswire/ -- On September 12th, the highly-anticipated RE+ 2023 commenced at The Venetian Convention and Expo Center in Las Vegas, USA. As the largest professional exhibition and trade fair for the solar energy industry in North America, RE+ drew in a massive crowd. Runergy made a splendid appearance at the event, showcasing a variety of flagship photovoltaic module products which were well-received by attendees. On the first day of the RE+ exhibition, Runergy made significant strides in expanding their global reach. Hyperion, the high-end module brand of Runergy, signed a global strategic agreement with Nanosun, targeting markets such as Europe, the Middle East, and the United States. Additionally, Hyperion entered into a strategic cooperation agreement with Grape Solar, focusing on the U.S. market. Mr. Mitchell Aguirre, COO of Nanosun, warmly expressed strong confidence in working with Hyperion to create innovative green energy solutions. Mr. Ocean Yuan, the founder and CEO of Grape Solar, emphasized that both companies share a commitment to partnership and strategic alliances, and that there is immense potential for future cooperation. At this year's RE+, Runergy showcased a series of high-efficiency modules that use the most cutting-edge N-type cell technology, as well as the mainstream PERC cell technology. Among them, the 54 half-cell N-Type high-efficiency module is featured with full black aesthetic design that will fit for rooftop applications and its light weight is easy and hands-on for installation. Though with small size, it is big on power, with maximum power output at 425W, creating higher return and shorter investment cycle for home owners. The other two N-Type modules are 72 and 78 half-cells, perfect for ground mounted projects and tracker systems. With Runergy's leading position in high-efficiency N-type cell R%D and manufacturing, these products offer project owners lower LCOE and greater long-term value. The 72 half-cell N-type module is also recognized as an Overall Highest Achiever, with top performance in all rigorous tests of three essential disciplines including quality, performance, and reliability by RETC. The company also presented the 72 half-cell single glass PERC module, produced at its factory in Thailand. Runergy has entered the photovoltaic industry since ten years ago and its accumulated cell shipments exceeds 50GW. Runergy is dedicated to continuously providing high-efficiency products with high value for global customers. During this magnificent solar industry event, Runergy hosted a grand customer appreciation and 10th anniversary gala dinner, known as "Runergy's Night," at the Palms Casino Resort Hotel in Las Vegas. Dr. Longzhong Tao, Chairman of Runergy, and Ms. Ellen Wang, the head of global sales of Runergy, were in attendance. Dr. Longzhong Tao expressed his heartfelt gratitude to the guests, while Ms. Ellen Wang reviewed the development history of Runergy over the past decade and shared her vision for the future. The evening's activities included the cutting of a "10th Anniversary Cake," customer sharing, music performances, and other exciting events. Attendees spoke highly of Runergy's products, development concepts, and future vision, expressing their eagerness to work hand-in-hand with Runergy. Runergy Group was founded in 2013. After ten years of development and innovation, and with the support and care of its partners, it has grown into a photovoltaic enterprise with more than 10,000 employees worldwide, leading solar cell sales, and a global industrial chain. In the future, Runergy will continue to optimize the industrial chain layout, take root in technological exploration, expand internationalization, build long-term competitiveness, and work with global partners to create a reliable new energy brand for users. Learn more about Runergy: https://www.runergy-solar.com/
A12 藝術空間
partnership
請先登入後才能發佈新聞。
還不是會員嗎？立即 加入台灣產經新聞網會員 ，使用免費新聞發佈服務。 （服務項目） （投稿規範）
